REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 159 filers reported holding REVANCE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $341,255 | -25.4% | 13,483 | -5.0% | 0.00% | 0.0% |
Q1 2023 | $457,382 | +69.4% | 14,200 | +46.5% | 0.00% | 0.0% |
Q3 2021 | $270,000 | -5.9% | 9,691 | 0.0% | 0.00% | – |
Q2 2021 | $287,000 | -36.6% | 9,691 | -40.2% | 0.00% | -100.0% |
Q1 2021 | $453,000 | -9.2% | 16,208 | -7.9% | 0.00% | 0.0% |
Q4 2020 | $499,000 | -1.4% | 17,594 | -12.6% | 0.00% | 0.0% |
Q3 2020 | $506,000 | +55.7% | 20,141 | +51.4% | 0.00% | 0.0% |
Q2 2020 | $325,000 | +61.7% | 13,303 | +64.5% | 0.00% | – |
Q3 2018 | $201,000 | -44.8% | 8,086 | -39.0% | 0.00% | – |
Q2 2018 | $364,000 | -10.6% | 13,249 | +0.3% | 0.00% | – |
Q1 2018 | $407,000 | -11.5% | 13,210 | +2.8% | 0.00% | – |
Q4 2017 | $460,000 | +60.8% | 12,854 | +23.7% | 0.00% | – |
Q3 2017 | $286,000 | +74.4% | 10,391 | -13.9% | 0.00% | – |
Q2 2016 | $164,000 | -38.1% | 12,073 | -20.5% | 0.00% | – |
Q1 2016 | $265,000 | -38.1% | 15,187 | +21.3% | 0.00% | -100.0% |
Q4 2015 | $428,000 | – | 12,521 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Essex Woodlands Management, Inc. | 3,342,047 | $94,714,000 | 24.58% |
Palo Alto Investors LP | 2,673,313 | $75,762,000 | 3.97% |
Evolutionary Tree Capital Management, LLC | 89,348 | $2,532,000 | 1.93% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,121,152 | $31,773,000 | 1.12% |
ArrowMark Colorado Holdings LLC | 2,964,135 | $84,004,000 | 0.65% |
Rhenman & Partners Asset Management AB | 220,000 | $6,235,000 | 0.51% |
Fosun International Ltd | 233,841 | $6,627,000 | 0.43% |
OSTERWEIS CAPITAL MANAGEMENT INC | 174,970 | $4,959,000 | 0.30% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 76,671 | $2,173,000 | 0.27% |
Tekla Capital Management LLC | 213,808 | $6,059,000 | 0.21% |